SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

N. Macedonia's Replek posts steep rise in 9-mo net profit

Nov 1, 2023, 11:30:19 AMArticle by Dragana Petrushevska
share
November 1 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its consolidated net profit reached 110.7 million denars ($1.9 million/1.8 million euro) in the first nine months of 2023, compared to just 38.2 million denars booked for the same period last year.

N. Macedonia's Replek posts steep rise in 9-mo net profit

Replek's operating revenue was up 26% on the year to 1.1 billion denars in January-September, whereas operating costs were 19% higher at 1 billion denars, the company said in an interim financial statement filed with the Skopje bourse on Tuesday.

Sales revenues from the domestic market lost 17% on an annual comparison basis, standing at 245 million denars in the first nine months of the year. Sales revenues from abroad went up 52% to 876.9 million denars.

Replek's shares last traded at an average price of 87,000 denars on the Macedonian Stock Exchange (MSE) on October 6, according to the latest available bourse data.

(1 euro = 61.58 denars)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.